Recent

% | $
Quotes you view appear here for quick access.

IntelliPharmaCeutics International Inc. Message Board

  • meifud meifud Apr 15, 2014 1:54 PM Flag

    SEC form 20-F/A, Exhibit 4.64 (filed 4/14) allows Par to release it's own generic focalin

    all they need is agreement with manufacturer of branded drug
    it's right there for all you pumpers to read, provided you can put down the pompoms long enough

    question -- who always claims it is a conspiracy or some skullduggery whenever the stock goes down but never when it goes up?
    answer -- this board's resident resolute cheerleaders who refuse to believe inconvenient truths

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • it's all there in ipci's filings with the SEC -- the reasons why institutions have been dumping (over 2 million shares last qtr) and shorts have been climbing aboard and insiders have not bought a single share -- it's all there for all who do not choose to be willfully ignorant

      and, revenue sharing is NOT specified for ipci -- indeed, the filing acknowledges Par was already working on its own version using different technology and that Par is entitled to proceed

      newbies, do not believe the creative pompom pumping nonsense that spews from the self-serving cheerleaders of this board

    • You forget to mention that PAR will still share the revenues with IPCI if it does release it's own focalin. So IPCI stands to GAIN not lose. Again, you spew mistruths.

      Sentiment: Strong Buy

 
IPCI
1.56-0.04(-2.61%)Jun 24 3:57 PMEDT